Isolation and Characterization of a Folate Receptor Mrna-Binding Trans-Factor from Human Placenta
Xu Xiao,Ying Tang,Janet Y. Mackins,Xin Sun,Hiremagalur N. Jayaram,Deborah K. Hansen,Asok Antony
DOI: https://doi.org/10.1074/jbc.m106824200
2001-01-01
Abstract:The interaction of an 18-basecis-element in the 5′-untranslated region of human folate receptor (FR)-α mRNA with a cytosolic trans-factor protein is critical for the translation of FR (Sun, X.-L., and Antony, A. C. (1996) J. Biol. Chem. 271, 25539–25547). This trans-factor was isolated to apparent homogeneity as a 43- and 38-kDa doublet from human placenta using poly(U)-Sepharose, followed by preparative sodium dodecyl sulfate-polyacrylamide gel electrophoresis and electro-elution as major purification steps. Amino acid microsequencing of two cyanogen bromide-generated peptide fragments of the 43-kDa trans-factor revealed complete identity with 43-kDa heterogeneous nuclear ribonucleoprotein E1 (hnRNP E1). Purified specific rabbit anti-hnRNP E1 peptide antibodies (generated against a synthetic oligopeptide that was not represented in microsequenced peptides of the trans-factor) also recognized the purified trans-factor on Western blots. Conversely, the 18-base FR RNA cis-element also bound hnRNP E1 protein on Northwestern blots. Moreover, a 19-base RNAcis-element in the 3′-untranslated region of 15-lipoxygenase mRNA that is known to bind hnRNP E1 also interacted with placental 43-kDa trans-factor. In addition, several murine tissues containing a hnRNP E1-related protein (also known as αCP-1) readily interacted with the 18-base FR RNAcis-element. Finally, anti-hnRNP E1 antibodies specifically inhibited translation of FR in vitro in a dose-dependent manner, and the antibody effect could be reversed in a dose-dependent manner by either purifiedtrans-factor or hnRNP E1. Collectively, the data favor identity of the FR mRNA-binding trans-factor and hnRNP E1, confirm its critical role in the translation of FR, and highlight yet another role of multifunctional hnRNP E1 in eukaryotic mRNA regulation. The interaction of an 18-basecis-element in the 5′-untranslated region of human folate receptor (FR)-α mRNA with a cytosolic trans-factor protein is critical for the translation of FR (Sun, X.-L., and Antony, A. C. (1996) J. Biol. Chem. 271, 25539–25547). This trans-factor was isolated to apparent homogeneity as a 43- and 38-kDa doublet from human placenta using poly(U)-Sepharose, followed by preparative sodium dodecyl sulfate-polyacrylamide gel electrophoresis and electro-elution as major purification steps. Amino acid microsequencing of two cyanogen bromide-generated peptide fragments of the 43-kDa trans-factor revealed complete identity with 43-kDa heterogeneous nuclear ribonucleoprotein E1 (hnRNP E1). Purified specific rabbit anti-hnRNP E1 peptide antibodies (generated against a synthetic oligopeptide that was not represented in microsequenced peptides of the trans-factor) also recognized the purified trans-factor on Western blots. Conversely, the 18-base FR RNA cis-element also bound hnRNP E1 protein on Northwestern blots. Moreover, a 19-base RNAcis-element in the 3′-untranslated region of 15-lipoxygenase mRNA that is known to bind hnRNP E1 also interacted with placental 43-kDa trans-factor. In addition, several murine tissues containing a hnRNP E1-related protein (also known as αCP-1) readily interacted with the 18-base FR RNAcis-element. Finally, anti-hnRNP E1 antibodies specifically inhibited translation of FR in vitro in a dose-dependent manner, and the antibody effect could be reversed in a dose-dependent manner by either purifiedtrans-factor or hnRNP E1. Collectively, the data favor identity of the FR mRNA-binding trans-factor and hnRNP E1, confirm its critical role in the translation of FR, and highlight yet another role of multifunctional hnRNP E1 in eukaryotic mRNA regulation. folate receptor heterogeneous nuclear ribonucleoprotein E1 fast flow liquid chromatography glutathione S-transferase dithiothreitol phenylmethylsulfonyl fluoride untranslated region reverse transcription polymerase chain reaction polyacrylamide gel electrophoresis 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic acid Folate receptors (FR)1mediate the cellular uptake of physiologic folates and some antifolates in normal and malignant cells (reviewed in Refs. 1Antony A.C. Blood. 1992; 79: 2807-2820Crossref PubMed Google Scholar and 2Antony A.C. Annu. Rev. Nutr. 1996; 16: 501-521Crossref PubMed Scopus (500) Google Scholar). Human placenta is rich in FR and was the source from which FR were first isolated to apparent homogeneity as a truncated species (3Antony A.C. Utley C. Van Horne K.C. Kolhouse J.F. J. Biol. Chem. 1981; 256: 9684-9692Abstract Full Text PDF PubMed Google Scholar) through the action of an endogenous metalloprotease (4Antony A.C. Verma R.S. Unune A.R. LaRosa J.A. J. Biol. Chem. 1989; 264: 1911-1914Abstract Full Text PDF PubMed Google Scholar, 5Yang X.Y. Mackins J.Y. Li Q.J. Antony A.C. J. Biol. Chem. 1996; 271: 11493-11499Abstract Full Text Full Text PDF PubMed Scopus (18) Google Scholar). The full-length FR species that are anchored to the membrane by glycosyl phosphatidylinositol anchoring (6Verma R.S. Gullapalli S. Antony A.C. J. Biol. Chem. 1992; 267: 4119-4127Abstract Full Text PDF PubMed Google Scholar) play a crucial role in transplacental maternal-to-fetal transport of folate (7Henderson G.I. Perez T. Schenker S. Mackins J. Antony A.C. J. Lab. Clin. Med. 1995; 126: 184-203PubMed Google Scholar). Among the three FR isoforms (designated α, β, and γ), the most ubiquitous is the α-isoform (referred hereafter as FR-α). In studies designed to identify the basis for the inverse relationship between the extracellular folate concentration and FR expression (8Kane M.A. Elwood P.C. Portillo R.M. Antony A.C. Najfeld V. Finley A. Waxman S. Kolhouse J.F. J. Clin. Invest. 1988; 81: 1398-1406Crossref PubMed Scopus (89) Google Scholar), we identified that the up-regulation of FR in cervical carcinoma cells is primarily at the translational level (9Antony A.C. Li Q.-J. Sun X.-L. Xiao X. Tang Y.-S. Kuttan R. Kuttan G. Proceedings of the 19th Annual Convention of the Indian Association for Cancer Research & Symposium on Biology of Cancer. Thrissur, Kerala, India2000Google Scholar). 2A. C. Antony, Y.-S. Tang, M. P. Biju, X. Xiao, Q.-J. Li, X.-L. Sun, H. N. Jayaram, and S. P. Stabler, unpublished data. 2A. C. Antony, Y.-S. Tang, M. P. Biju, X. Xiao, Q.-J. Li, X.-L. Sun, H. N. Jayaram, and S. P. Stabler, unpublished data. Further studies identified a 46-kDa cytosolic protein in human cervical carcinoma cells, which specifically interacted with a CU-rich 18-basecis-element in the 5′-untranslated region (5′-UTR) of human FR-α mRNA, and that this interaction was critical for the translation of FR in vitro (10Sun X.L. Antony A.C. J. Biol. Chem. 1996; 271: 25539-25547Abstract Full Text Full Text PDF PubMed Google Scholar). Moreover, because this FR mRNA-binding trans-factor was widely distributed in cells expressing little to no FR-α, we predicted that this RNA-binding protein probably has additional functions that are unrelated to FR translation (10Sun X.L. Antony A.C. J. Biol. Chem. 1996; 271: 25539-25547Abstract Full Text Full Text PDF PubMed Google Scholar). RNA-binding proteins are known to play a pivotal role in the metabolism, function, and fate of RNA in the post-transcriptional regulation of gene expression (11Klausner R.D. Harford J.B. Science. 1989; 246: 870-872Crossref PubMed Scopus (227) Google Scholar, 12Krecic A.M. Swanson M.S. Curr. Opin. Cell Biol. 1999; 11: 363-371Crossref PubMed Scopus (709) Google Scholar, 13McCarthy J.E.G. Microbiol. Mol. Biol. Rev. 1998; 62: 1492-1553Crossref PubMed Google Scholar, 14McCarthy J.E. Kollmus H. Trends Biochem. Sci. 1995; 20: 191-197Abstract Full Text PDF PubMed Scopus (153) Google Scholar). In the past decade, several groups of RNA-binding proteins have been identified (15Ostareck-Lederer A. Ostareck D.H. Hentze M.W. Trends Biochem. Sci. 1998; 23: 409-411Abstract Full Text Full Text PDF PubMed Scopus (157) Google Scholar, 16Cusack S. Curr. Opin. Struct. Biol. 1999; 9: 66-73Crossref PubMed Scopus (84) Google Scholar) that are variously involved in mRNA stability, storage, splicing, transportation, and translational regulation. Accordingly, to characterize the FR mRNA-binding trans-factor (10Sun X.L. Antony A.C. J. Biol. Chem. 1996; 271: 25539-25547Abstract Full Text Full Text PDF PubMed Google Scholar), and further understand the role of this trans-factor in regulation of FR expression at the translational level, we isolated and characterized this protein from human placenta, which is a rich source. In this report, we present evidence that favors identity of the FR mRNA-binding trans-factor with heterogeneous nuclear ribonucleoprotein E1 (hnRNP E1). In addition, functional analysis of this protein using antibodies against hnRNP E1 confirms its critical role in the biosynthesis of FR at the translational level. Restriction endonucleases, T4 DNA ligase, RNase A, RNase T1, proteinase K, RNase inhibitor, mRNA isolation kit, and the in vitro transcription kit (containing pSPT-18/19 plasmids) were from Roche Molecular Biochemicals. Unless noted otherwise, all other chemicals of the highest analytical grade were from Sigma. Full-length FR-α cDNA inserted in a pUC8 plasmid (17Elwood P.C. J. Biol. Chem. 1989; 264: 14893-14901Abstract Full Text PDF PubMed Google Scholar) was a gift from Dr. P. C. Elwood. Sense and antisense 18-base DNA oligonucleotides corresponding to the FR-α mRNAcis-element (10Sun X.L. Antony A.C. J. Biol. Chem. 1996; 271: 25539-25547Abstract Full Text Full Text PDF PubMed Google Scholar) and sense and antisense oligonucleotides corresponding to the 19-base cis-element in the 3′-UTR of 15-lipoxygenase RNA (25Funke B. Zuleger B. Benavente R. Schuster T. Goller M. Stevenin J. Horak I. Nucleic Acids Res. 1996; 24: 3821-3828Crossref PubMed Scopus (38) Google Scholar) were synthesized by Life Technologies, Inc. The DNA sequencing kit (Sequenase version 2.0), [α-32P]UTP, [α-32P]CTP (specific activity >3000 Ci/mmol), [α-32P]ATP, Redivue Pro-Mix [35S]methionine, all FPLC HiTrap chromatography columns, fast flow liquid chromatography (FPLC) equipment, and GST fusion protein expression vector PGEX4T-1 were from Amersham Pharmacia Biotech(Uppsala, Sweden). Mini-SDS-PAGE electrophoresis cell, mini-trans-blot transfer cell, and SDS-PAGE ready gels were from Bio-Rad. Access RT-PCR introductory system and the 5′ end labeling kit were from Promega (Madison, WI). Plasmid preparation kits were from Qiagen (Valencia, CA). The 1.1-kilobase pair full-length human FR-α cDNA, which was subcloned into the pSPT18 vector downstream of the SP6 RNA polymerase promoter, was designated pSPT18-FR-α (10Sun X.L. Antony A.C. J. Biol. Chem. 1996; 271: 25539-25547Abstract Full Text Full Text PDF PubMed Google Scholar). To construct a plasmid containing the 18-base FR-α cis-element, sense and antisense oligonucleotides containing two 18-base oligonucleotide repeats with PstI andBamHI restriction sites at the ends were synthesized. After annealing the sense and antisense oligonucleotides and restriction enzyme digestion, the DNA fragment was subcloned into the pSPT18 vector between restriction sites PstI and BamHI. The new plasmid was designated as pXL37A. The 18-base sequence (see Fig.4A) was determined by DNA sequencing. To prepare the 18-base cis-element RNA fragment, pXL37A was linearized byPstI. To prepare radiolabeled RNA probe, [α-32P]UTP was included in the transcription reaction, and RNA transcripts were purified using NucTrap push-through Sephadex G-50 columns (Stratagene, La Jolla, CA). 5′ end labeling was used to prepare γ-32P-labeled 18-base DNA oligonucleotide probes. Double-stranded 18-base pair DNA was generated by annealing equimolar amounts of single-stranded sense and antisense 18-base oligonucleotides by heating at 95 °C for 5 min followed by cooling to 22 °C. RNA-protein binding reactions and electrophoretic mobility gel-shift assay (18Leibold E.A. Munro H.N. Proc. Natl. Acad. Sci. U. S. A. 1988; 85: 2171-2175Crossref PubMed Scopus (555) Google Scholar) were performed as described (10Sun X.L. Antony A.C. J. Biol. Chem. 1996; 271: 25539-25547Abstract Full Text Full Text PDF PubMed Google Scholar). In some experiments, reducing or oxidizing reagents were added to the reactions to detect effects on the RNA-protein interaction. Briefly,32P-labeled cis-element (10,000 cpm) was reacted for 30 min at 22 °C with 20 µg of partially purified placental cytosolic extract (that had been dialyzed to remove dithiothreitol (DTT)) with various concentrations of dithiothreitol,dl-homocysteine, l-cysteine,N-ethylmaleimide, or oxidized dithiothreitol. After addition of RNase T1 and heparin and incubation for 20 min, RNA-protein complexes were electrophoresed (native PAGE) followed by autoradiography (10Sun X.L. Antony A.C. J. Biol. Chem. 1996; 271: 25539-25547Abstract Full Text Full Text PDF PubMed Google Scholar). To semiquantitatively estimate the relative recovery of FR mRNA-binding trans-factor during each purification step, aliquots from each step were analyzed using a single preparation of 32P-labeled 18-base cis-element probe of known specific activity. The binding of a fixed amount of excess RNA probe with trans-factor present in each purification step was determined by a gel-shift assay. After drying the gel on Whatman paper, the areas of RNA-protein complexes (verified by autoradiography) were excised and immersed in 10 ml of Biosafe II counting mixture (Research Products International), and radioactivity was determined by liquid scintillation counting. Functionally active trans-factor was monitored during each purification step by Northwestern blots. Briefly, various aliquots oftrans-factor protein were first separated on a 4–20% gradient SDS-PAGE mini-gels by electrophoresis before Northwestern blot analysis using 32P-labeled 18-base cis-element RNA probes (10Sun X.L. Antony A.C. J. Biol. Chem. 1996; 271: 25539-25547Abstract Full Text Full Text PDF PubMed Google Scholar). For Southwestern blot analysis, following SDS-PAGE and transfer to nitrocellulose, the separated proteins were probed with32P-labeled 18-base single-stranded or double-stranded DNA probes. Cytosolic protein extracts (S-100 fraction) from 5 × 107Hela-IU1 cells were prepared as described (10Sun X.L. Antony A.C. J. Biol. Chem. 1996; 271: 25539-25547Abstract Full Text Full Text PDF PubMed Google Scholar). Placental cytosolic extracts were prepared as follows. Full-term placentas were collected in an ice bath shortly after normal vaginal delivery and processed within 4 h of delivery. After removal of the umbilical cord, membranes, blood clots, and necrotic tissue, each placenta was diced into 2 × 2-cm pieces and then washed twice with 1000 ml of 75 mm potassium phosphate (pH 7.5) prior to homogenization in two volumes of 10 mm potassium phosphate (pH 7.5) (Buffer A). After centrifugation at 30,000 × g for 30 min, the supernatant was supplemented with 1 mm DTT and 0.5 mm phenylmethylsulfonyl fluoride (PMSF) and filtered through a Minitan ultrafiltration system (Millipore Corp, Bedford, MA) using a 300,000 Mr cut-off. The sample was then concentrated over a 30,000 Mr cut-off membrane to a final volume of 50 ml/placenta. After the addition of 10% glycerol (v/v), the sample was frozen at −80 °C until further use. The protein concentration of the cytosolic extracts from human placenta (hereafter referred to as “crude sample”) was determined using the BCA method. Nuclear extracts from human placenta were also prepared as described (19Gorski K. Carneiro M. Schibler U. Cell. 1986; 47: 767-776Abstract Full Text PDF PubMed Scopus (972) Google Scholar). Unless otherwise stated, all purification steps (Table I) were carried out at 4 °C and RNA binding activity was detected by Northwestern blot analysis. The crude sample was thawed to 4 °C and trans-factor was precipitated by 40% saturated ammonium sulfate. The pellet was rinsed with 40% saturated ammonium sulfate, following which thetrans-factor was dissolved in 10 ml of Buffer B (10 mm potassium phosphate, pH 7.0, containing 0.6m ammonium sulfate, 1 mm DTT, 0.5 mm PMSF, and 10% (v/v) glycerol). The sample was then loaded onto a 5-ml HiTrap phenyl-Sepharose CL-4B column that was equilibrated with Buffer B using a Pharmacia FPLC system. After loading the sample and washing with 10 column volumes of 50% Buffer B plus 50% Buffer C (10 mm potassium phosphate, pH 7.0, containing 0.5% CHAPS, 1 mm DTT, 0.5 mm PMSF, 10% (v/v) glycerol), the trans-factor was eluted with Buffer C and fractions of 0.5 ml were collected.Table IPurification of the FR mRNA-binding trans-factorFractionsVolumeConcentrationProteinUnits1-aOne unit of activity corresponds to 1 pmol of bound RNA/mg of protein in the standard gel-shift assay.Specific activityYieldPurificationmlmg/mlmgpmol/mg%-foldLysate1-bThe lysate was derived from six placentas.762510.479,300NDUltrafiltration65018.712,20053,6624.41001Ammonium sulfate708.66047,63212.614.22.8Phenyl-Sepharose501.1553,15557.45.910.8Heparin-Sepharose7.52151,37591.72.620.8Poly(U)-Sepharose100.080.8638.5792.81.2181.5ND, not determined.1-a One unit of activity corresponds to 1 pmol of bound RNA/mg of protein in the standard gel-shift assay.1-b The lysate was derived from six placentas. Open table in a new tab ND, not determined. The eluted fractions containing RNA binding activity (fractions 5–9) were pooled and directly loaded onto a HiTrap heparin column (consisting of five 1-ml columns connected in series; Amersham Pharmacia Biotech) that was equilibrated and washed with Buffer C until the absorbance at an optical density of 280 was at base line. The proteins that remained bound to the column were eluted with 50 ml of Buffer B with KCl in a linear gradient from 0 to 1000 mm, and trans-factor-positive fractions (eluting between 0.3 and 0.4 m KCl) were pooled and diluted with an equal volume of Buffer C. After adding rRNA (35 µg/ml), tRNA (20 µg/ml), and RNase inhibitor (40 units/ml), the mixture was applied to a 5-ml HiTrap poly(U)-Sepharose 4B column, which was equilibrated with Buffer C. After washing the column with Buffer C until base-line optical density of 280 readings were obtained, the sample was eluted with 50 ml of Buffer C with KCl in a linear gradient of 0–1000 mm. Fractions of 0.5 ml were collected, andtrans-factor-positive fractions (eluting between 0.38 and 0.6 m KCl) were dialyzed against Buffer C using Slide-a-lyzer dialysis cassettes (Pierce). Finally, the sample was filtered (0.2 µm) and stored at −80 °C. Purified proteins (following the poly(U)-Sepharose step) were electrophoresed on 10% SDS-PAGE. Pre-stained protein markers (Bio-Rad) were loaded on either sides of the gel. Following electrophoresis, the band corresponding to the trans-factor was excised and the proteins were electro-eluted in 2-ml dialysis bags containing 25 mm Tris-glycine and 0.1% SDS. After filtration through 0.2-µm filters, PMSF and DTT were added to achieve a final concentration of 0.5 and 1 mm, respectively. Renaturation of the eluted protein from SDS-PAGE gel was carried out with minor modification (20Hager D.A. Burgess R.R. Anal. Biochem. 1980; 109: 76-86Crossref PubMed Scopus (813) Google Scholar). Briefly, four volumes of acetone (−20 °C) were added and proteins were allowed to precipitate for 30 min in a dry ice-ethanol bath. Following centrifugation at 12,000 × g for 10 min, the pellet was rinsed with 80% acetone. After drying at 22 °C, the pellet was first dissolved in 20-µl of 6 m guanidine HCl in phosphate-buffered saline for 20 min at 22 °C, followed by 50-fold dilution in Northwestern binding buffer (10 mm Tris-HCl, pH 7.4, containing 50 mm NaCl, 1 mm EDTA, and 1× Denhardt's solution in diethyl pyrocarbonate-treated water). The protein was allowed to renature over the ensuing 12 h at 22 °C, following which the protein was concentrated using Centricon concentrators (Amicon, Beverly, MA) and analyzed for trans-factor activity. In pilot experiments (see legend to Fig. 1D), several other renaturing buffers were employed in place of Northwestern binding buffer. After SDS-PAGE separation and trans-blotting onto polyvinylidene difluoride membranes (Immobilon-PSQ, Millipore) and staining, the band corresponding to the purified FR mRNA-binding trans-factor was excised. After cyanogen bromide digestion and separation of peptide fragments, or furtherO-phthalaldehyde treatment, two peptide fragments of the 43-kDa and one fragment of the 38-kDa species were microsequenced (ProSeq, Boston, MA). The results of microsequencing were analyzed within the GenBank™ data base using the BLAST program. The mRNA from HeLa-IU1 cells was isolated, and the coding region of hnRNP E1 cDNA was cloned by Access RT-PCR and EcoRI and XhoI sites were introduced into each end of the amplified cDNA fragments. After restriction enzyme digestion, the RT-PCR fragment was inserted intoEcoRI and XhoI linearized GST fusion protein expression vector PGEX4T-1. The recombinant plasmid was transformed to BL21 Escherichia coli, and a positive clone was verified by restriction enzyme mapping and DNA sequencing (Merlin Core Service, Carlsbad, CA), which confirmed that the insert was hnRNP E1. Following induction by 0.2 mmisopropyl-1-thio-β-d-galactopyranoside, the GST-hnRNP E1 fusion protein was purified by glutathione-Sepharose-4B affinity chromatography. Recombinant hnRNP E1 protein was released by cleavage of the fusion protein with thrombin (0.5 units/ml), and proteins were analyzed by SDS-PAGE, Northwestern blotting using32P-labeled 18-base mRNA, and Western blotting using anti-peptide hnRNP E1 antibodies. An oligopeptide containing a 19-amino acid stretch of sequences (SLAQYLINARLSSEKGMGC) of hnRNP E1 was synthesized, acetylated at its N-terminal end, and after conjugation with keyhole limpet hemocyanin, rabbit antiserum was generated against this antigen by Animal Pharm Services, Inc. (Healdsburg, CA). Rabbit anti-hnRNP E1 (oligopeptide) antibodies were isolated by affinity chromatography using oligopeptide-Sepharose, and stored in 50 mm Tris-HCl, pH 7.5, containing 150 mm NaCl, and 1.0% sodium azide at −20 °C. Various proteins were analyzed by Western blots (21Nesbitt S.A. Horton M.A. Anal. Biochem. 1992; 206: 267-272Crossref PubMed Scopus (59) Google Scholar) using 1:10,000 diluted rabbit anti-hnRNP E1 (oligopeptide) antibodies that were detected with 1:10,000 dilution of horseradish peroxidase-conjugated goat anti-rabbit IgG (Promega, Madison, WI), followed by enhanced chemiluminescence detection and autoradiography. Female mice (C57 B6, 2 months old) were from Jackson Laboratories (Bar Harbor, ME). Placentas were obtained from CD-1 mice (Charles River, Wilmington, MA) on gestation day 17 and transported from Jefferson, AR, to Indianapolis, IN on dry ice. Murine tissues (bone marrow, liver, heart, kidney, brain, lung) were dissected and processed immediately after sacrifice. After S-100 fractions were prepared (10Sun X.L. Antony A.C. J. Biol. Chem. 1996; 271: 25539-25547Abstract Full Text Full Text PDF PubMed Google Scholar, 18Leibold E.A. Munro H.N. Proc. Natl. Acad. Sci. U. S. A. 1988; 85: 2171-2175Crossref PubMed Scopus (555) Google Scholar), gel-shift assays and Northwestern blots were carried out using human 18-base cis-element. In vitro transcription and translation were carried out using the protocol (Single Tube Protein System 3, SP6) from Novagen (Madison, WI). Briefly, after addition (0.5 µg/reaction) of DNA template (BglI linearized plasmid pSPT18 FR) to the transcription mix, the reaction mixture was incubated at 30 °C for 15 min, following which aliquots of the transcription reaction were applied to the translation reaction. In vitrotranslation was carried out using a rabbit reticulocyte lysate system in a 50-µl reaction mixture containing 30 µCi of [35S]methionine. Various amounts of purified human placental FR mRNA-binding trans-factor (or purified recombinant hnRNP E1) and/or purified rabbit anti-hnRNP E1 (oligopeptide) antibodies (or nonimmune serum) were included in the reticulocyte lysate 15 min before in vitro translation was begun. The translation reaction was incubated at 30 °C for 1 h, followed by addition of 1 µl of 10 mg/ml RNase A. After incubation at 22 °C for 5 min, the reaction mixture was separated by 12% SDS-PAGE, followed by autoradiography. The 19-base sequence in the 3′-UTR of 15-lipoxygenase mRNA (25Funke B. Zuleger B. Benavente R. Schuster T. Goller M. Stevenin J. Horak I. Nucleic Acids Res. 1996; 24: 3821-3828Crossref PubMed Scopus (38) Google Scholar) corresponding to its cDNA (2116CCCCACCCTCTTCCCCAAG2135) was synthesized as follows. The sequence pAATTCG was introduced to the 5′ end of the above sense oligodeoxynucleotide, and pAGCTT introduced to the 5′ end of the antisense sequence. The resulting double-stranded DNA was subcloned into the vector pSPT18 linearized with EcoRI andHindIII to construct a plasmid pYST03. This plasmid was introduced into DH5α bacteria. To prepare the sense 19-base RNA fragments, pYST03 was linearized with HindIII, and transcribed by T7 RNA polymerase in the presence of [α-32P]CTP. γ-32P-Labeled, single-stranded 19-base 15-lipoxygensase DNA oligonucleotides were generated with the DNA 5′ end labeling kit (Roche). These radiolabeled 19-base 15-lipoxygenase sense RNA and DNA were reacted with placentaltrans-factor and hnRNP E1 and analyzed by gel-shift assays, Northwestern, and Southwestern blots. Using gel-shift assays to monitor the interaction of cytosolic extracts from human placenta with 18-base α-32P-labeledcis-element from the 5′-UTR of human FR-α mRNA, we identified an RNA-protein interaction (Fig.1A). With increasing cytosolic extracts, there were progressively stronger signals confirming a dose-dependent relationship (Fig. 1A,lanes 1–5). The abrogation of signals in the presence of proteinase K (Fig. 1A, lane 6) suggested that proteins were among the components that interacted with the probe. Northwestern blot analysis using crude cytosolic extracts from human placenta revealed a 43-kDa mRNA-binding trans-factor protein (results not shown). When equivalent quantities of S-100 cytosolic and nuclear fractions were analyzed on Northwestern blots, the 43-kDa trans-factor protein was predominantly found in cytosolic rather than nuclear fraction (Fig. 1B). Progressive purification of the trans-factor was assessed by Northwestern blots and SDS-PAGE. Various properties of thetrans-factor were exploited in its purification from human placental cytosolic extracts (Table I; Fig. 1C). Although the predicted molecular mass of thetrans-factor was 43 kDa, trans-factor proteins were retained by a 100-kDa cut-off membrane; this suggested its association in a complex with other proteins. Accordingly, following ultrafiltration using a 300-kDa cut-off membrane, the sample was concentrated over a 30-kDa cut-off membrane. Fig. 1C shows the progressive purification of thetrans-factor using the purification scheme summarized in Table I. Following ammonium sulfate precipitation, thetrans-factor, which bound to a hydrophobic interaction column (phenyl-Sepharose), was further purified based on its resistance to elution by up to 80% of Buffer C. Therefore, after eluting other proteins, the trans-factor was eluted by Buffer C, which was supplemented with 0.5% CHAPS. (CHAPS was selected because several other ionic, nonionic, or zwitterionic detergents (Nonidet P-40, SDS, Triton X-100) affected the RNA-protein interaction). Thetrans-factor interacted with the heparin column at pH 7.0, following which it was eluted by a linear gradient of KCl. The 18-base cis-element is a C/U-rich sequence (containing 11 cytosine and 6 uridine residues). Although thetrans-factor interaction with the cis-element could be competed by poly(C) (but not by poly(U)) (10Sun X.L. Antony A.C. J. Biol. Chem. 1996; 271: 25539-25547Abstract Full Text Full Text PDF PubMed Google Scholar), the very strong interaction of the trans-factor with poly(C)-Sepharose precluded elution from this column with conventional buffers. Surprisingly, in the presence of CHAPS, we found that thetrans-factor could bind poly(U)-Sepharose and was eluted by a linear gradient of KCl. This was a key step in the purification scheme (Fig. 1C, lane 5). To eliminate minor protein staining bands (that were noted only on silver-stained SDS-PAGE) that co-eluted with the trans-factor following the poly(U)-Sepharose step, that portion of the gel containing the 43-kDatrans-factor was electro-eluted. An aliquot of this electro-eluted protein exhibited a single 43-kDa protein on repeat SDS-PAGE followed by silver staining. To prove that this protein was the trans-factor, another aliquot was denatured with guanidine and renatured and then assessed for the capacity to interact with the cis-element with gel-shift assays. As shown in Fig.1D, although there were no RNA-protein complexes when electro-eluted (denatured) 43-kDa trans-factor protein was assessed for RNA interaction, such RNA-protein complexes were best observed after the electro-eluted and denatured trans-factor was renatured with Northwestern binding buffer containing 1× Denhardt's solution (lane 9). Thus, the purified protein doublet that bound the 18-base RNA cis-element on Northwestern blots was the same protein that gave rise to the RNA-protein complexes on gel-shift assays. Accordingly, the electro-eluted, apparently homogeneous trans-factor was subjected to amino acid sequence analysis. After confirmation of apparent homogeneity based on SDS-PAGE, the trans-factor was characterized as follows. Earlier, we identified that the cervical carcinoma (HeLa-IU1) celltrans-factor had a Mr of 46,000; this was based on the use of prestained standards used in Northwestern blots (10Sun X.L. Antony A.C. J. Biol. Chem. 1996; 271: 25539-25547Abstract Full Text Full Text PDF PubMed Google Scholar). However, using unstained Mr standards, the same 46-